Cellectar Biosciences, Inc. Liabilities, Noncurrent
Cellectar Biosciences, Inc. (CLRB) had Liabilities, Noncurrent of $301.74 thousand as of 2020-12-31, per its 10-K filed 2021-03-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2021-03-02
- 2020-12-31: Liabilities, Noncurrent $301.74K.
- 2020-09-30: Liabilities, Noncurrent $517.38K.
- 2020-06-30: Liabilities, Noncurrent $547.53K.
- 2020-03-31: Liabilities, Noncurrent $392.95K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2020-12-31 | $301.74K 10-K · filed 2021-03-02 |
| 2020-09-30 | $517.38K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $547.53K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $392.95K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $421.64K 10-K · filed 2021-03-02 |
| 2019-09-30 | $449.63K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $476.25K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $502.21K 10-Q · filed 2019-05-06 |
| 2018-12-31 | $171.00K 10-K · filed 2020-03-09 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-13 |
| 2018-06-30 | $568.00 10-Q · filed 2018-08-10 |
| 2018-03-31 | $1.40K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $2.21K 10-K · filed 2019-02-26 |
| 2017-09-30 | $146.04K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $147.92K 10-Q · filed 2017-08-14 |
| 2017-03-31 | $149.89K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $151.83K 10-K · filed 2018-03-21 |
| 2016-09-30 | $153.76K 10-Q · filed 2016-11-10 |
| 2016-06-30 | $154.92K 10-Q · filed 2016-08-11 |
| 2016-03-31 | $180.81K 10-Q · filed 2016-05-12 |
| 2015-12-31 | $243.53K 10-K · filed 2017-03-15 |
| 2015-09-30 | $305.78K 10-Q · filed 2015-11-12 |
| 2015-06-30 | $367.01K 10-Q · filed 2015-08-12 |
| 2015-03-31 | $427.78K 10-Q · filed 2015-05-20 |
| 2014-12-31 | $488.98K 10-K/A · filed 2016-10-20 |
| 2014-09-30 | $505.09K 10-Q · filed 2015-05-20 |
| 2014-06-30 | $4.35M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $4.36M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $593.23K 10-Q · filed 2015-05-20 |
| 2013-09-30 | $591.85K 10-Q · filed 2013-11-13 |
| 2013-06-30 | $590.23K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $588.67K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $587.10K 10-K · filed 2014-03-19 |
| 2012-09-30 | $585.52K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $583.27K 10-Q · filed 2012-08-09 |
| 2012-03-31 | $580.88K 10-Q · filed 2012-05-04 |
| 2011-12-31 | $578.47K 10-K · filed 2013-03-28 |
| 2011-09-30 | $576.06K 10-Q · filed 2011-11-07 |
| 2011-06-30 | $573.67K 10-Q · filed 2011-08-12 |
| 2010-12-31 | $3.76M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |